Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurobit Technologies has developed a commercialized intelligent health platform that leverages visual physiological signals—especially eye movements—combined with AI analytics to enable early diagnosis of neurological conditions such as stroke or vertigo. Their solutions are trusted by clinicians across several specialties. The company’s "NeuroSpeed" device enables rapid screening of stroke/brain diseases via portable oculomotor analysis. Clinical results include validated use in hospital settings for early-stage diagnosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neurobit Technologies.